EP1556490A4 - Nouveaux acides nucleiques et polypeptides - Google Patents

Nouveaux acides nucleiques et polypeptides

Info

Publication number
EP1556490A4
EP1556490A4 EP03815295A EP03815295A EP1556490A4 EP 1556490 A4 EP1556490 A4 EP 1556490A4 EP 03815295 A EP03815295 A EP 03815295A EP 03815295 A EP03815295 A EP 03815295A EP 1556490 A4 EP1556490 A4 EP 1556490A4
Authority
EP
European Patent Office
Prior art keywords
polypeptides
nucleic acids
new nucleic
new
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03815295A
Other languages
German (de)
English (en)
Other versions
EP1556490A2 (fr
Inventor
Y Tom Tang
Vinod Asundi
Feiyan Ren
Jie Zhang
Tom Wehrman
Zhiwei Wang
Yunqing Ma
Dunrui Wang
Rui-Hong Chen
Qing A Zhao
Jian-Rui Wang
Malabika Ghosh
Aidong J Xue
Gezhi Weng
Ping Zhou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nuvelo Inc
Original Assignee
Nuvelo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nuvelo Inc filed Critical Nuvelo Inc
Publication of EP1556490A2 publication Critical patent/EP1556490A2/fr
Publication of EP1556490A4 publication Critical patent/EP1556490A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EP03815295A 2002-10-22 2003-09-30 Nouveaux acides nucleiques et polypeptides Withdrawn EP1556490A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US416186P 2002-10-02
US41618602P 2002-10-22 2002-10-22
PCT/US2003/030720 WO2004080148A2 (fr) 2002-10-02 2003-09-30 Nouveaux acides nucleiques et polypeptides

Publications (2)

Publication Number Publication Date
EP1556490A2 EP1556490A2 (fr) 2005-07-27
EP1556490A4 true EP1556490A4 (fr) 2006-04-05

Family

ID=32990311

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03815295A Withdrawn EP1556490A4 (fr) 2002-10-22 2003-09-30 Nouveaux acides nucleiques et polypeptides

Country Status (5)

Country Link
EP (1) EP1556490A4 (fr)
JP (1) JP2006517094A (fr)
AU (1) AU2003303305A1 (fr)
CA (1) CA2500521A1 (fr)
WO (1) WO2004080148A2 (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0209884D0 (en) 2002-04-30 2002-06-05 Ares Trading Sa Proteins
EP2311468B1 (fr) * 2003-08-08 2014-01-15 Perseus Proteomics Inc. Gène surexprimé dans le cancer
US20070037204A1 (en) * 2003-08-08 2007-02-15 Hiroyuki ABURANTAI Gene overexpressed in cancer
US7534562B2 (en) 2003-09-30 2009-05-19 Daiichi Pharmaceutical Co., Ltd. Tetrahydrofolate synthetase gene
PL2157192T3 (pl) 2003-10-10 2014-01-31 Deutsches Krebsforsch Kompozycje do diagnozowania i terapii chorób związanych z nieprawidłową ekspresją futrin (R-spondin)
CN1902494B (zh) * 2003-11-03 2010-10-27 伊西康公司 用于检测广谱细菌的方法、肽和生物传感器
GB0326393D0 (en) 2003-11-12 2003-12-17 Ares Trading Sa Cytokine antagonist molecules
JPWO2005070964A1 (ja) * 2004-01-27 2008-01-17 株式会社医学生物学研究所 単球の単離方法
US20100031378A1 (en) 2008-08-04 2010-02-04 Edwards Joel A Novel gene disruptions, compositions and methods relating thereto
WO2005079566A2 (fr) * 2004-02-12 2005-09-01 Lexicon Genetics Incorporated Nouvelles disruptions geniques, compositions et procedes associes
PL2031063T3 (pl) * 2004-06-18 2014-04-30 Univ Duke Modulatory receptorów węchowych
EP2479277B1 (fr) 2004-07-22 2015-09-02 Five Prime Therapeutics, Inc. L'utilisation de MGD-CSF dans le traitement de maladie d'Alzheimer
US20090087474A1 (en) * 2005-01-07 2009-04-02 Petersen Thomas N Therapeutic use of growth factors,nsg29 and nsg31
GB0517466D0 (en) * 2005-08-26 2005-10-05 Immunodiagnostic Systems Plc Diagnostic assay and therapeutic treatment
WO2008046649A1 (fr) 2006-10-20 2008-04-24 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Utilisation de rspondins en tant que modulateurs de l'angiogenèse et de la vasculogenèse
AU2008222580A1 (en) * 2007-03-07 2008-09-12 The Council Of The Queensland Institute Of Medical Research Novel human ssDNA binding proteins and methods of cancer diagnosis
PT2186889E (pt) 2007-08-20 2015-06-17 Oncotherapy Science Inc Péptido cdca1 e agente farmacêutico que o compreende
CN102099055A (zh) 2007-10-04 2011-06-15 津莫吉尼蒂克斯公司 B7家族成员zB7H6及相关的组合物和方法
JP5547637B2 (ja) * 2007-10-05 2014-07-16 インデックス・ファーマシューティカルズ・アクチエボラーグ 浮腫を治療または軽減するための新規な化合物およびその使用方法
PT3106874T (pt) * 2007-10-25 2020-05-08 Toray Industries Método para a deteção de cancro
JP5572938B2 (ja) * 2007-10-25 2014-08-20 東レ株式会社 免疫誘導剤
ES2660414T3 (es) * 2007-10-25 2018-03-22 Toray Industries, Inc. Inductor de la respuesta inmunitaria
US8198406B2 (en) * 2007-11-07 2012-06-12 Northwestern University Methods and compositions for inhibiting angiogenesis
US9096689B2 (en) * 2007-11-07 2015-08-04 Northwestern University Methods and compositions for inhibiting angiogenesis
WO2009086106A1 (fr) * 2007-12-21 2009-07-09 Mount Sinai School Of Medicine Of New York University Utilisation de protéine de podocan dans le traitement de maladies cardiovasculaires
TWI526219B (zh) 2008-06-19 2016-03-21 腫瘤療法 科學股份有限公司 Ｃｄｃａ１抗原決定位胜肽及含此胜肽的疫苗
EP2872532A4 (fr) 2012-07-10 2016-04-13 Oncotherapy Science Inc Peptides épitopes du cdca1 pour cellules th1 et vaccins les contenant
CN105188749B (zh) 2012-12-21 2017-12-19 西雅图基因公司 抗ntb‑a抗体及相关组合物和方法
US20180305451A1 (en) * 2015-07-13 2018-10-25 Compugen Ltd. Hide1 compositions and methods
GB201520568D0 (en) * 2015-11-23 2016-01-06 Immunocore Ltd Peptides
GB201520550D0 (en) 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
CN106047818A (zh) * 2016-08-05 2016-10-26 武汉赛云博生物科技有限公司 癌胚抗原特异性tcr基因修饰的t细胞及其抑癌用途
TW202023581A (zh) 2018-08-02 2020-07-01 日商腫瘤療法 科學股份有限公司 來自cdca1的胜肽及含有此的疫苗
WO2020117715A1 (fr) 2018-12-03 2020-06-11 Board Of Regents, The University Of Texas System Analogues d'oligo-benzamide et leur utilisation dans le traitement du cancer

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001090366A2 (fr) * 2000-05-24 2001-11-29 Curagen Corporation Nouveaux polynucleotides humains et polypeptides codes par celui-ci

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001090366A2 (fr) * 2000-05-24 2001-11-29 Curagen Corporation Nouveaux polynucleotides humains et polypeptides codes par celui-ci

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 29 January 2002 (2002-01-29), "Homo sapiens BAC clone RP11-386I19 from 4, complete sequence.", XP002354641, retrieved from EBI accession no. EM_PRO:AC108139 Database accession no. AC108139 *
THE SANGER CENTRE (UK) AND THE WASHINGTON UNIVERSITY GENOME SEQUENCING CENTER (USA): "Toward a complete human genome sequence", GENOME RESEARCH, COLD SPRING HARBOR LABORATORY PRESS, US, vol. 8, no. 11, November 1998 (1998-11-01), pages 1097 - 1108, XP002169000, ISSN: 1088-9051 *

Also Published As

Publication number Publication date
AU2003303305A1 (en) 2004-09-30
WO2004080148A3 (fr) 2005-03-31
EP1556490A2 (fr) 2005-07-27
JP2006517094A (ja) 2006-07-20
CA2500521A1 (fr) 2004-09-23
WO2004080148A2 (fr) 2004-09-23

Similar Documents

Publication Publication Date Title
EP1556490A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1504099A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1432800A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1325120A4 (fr) Acides nucleiques et polypeptides
EP1341804A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1242443A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1368475A4 (fr) Nouveaux acides nucleiques et nouveaux polypeptides
ATE554171T1 (de) Rezeptor-nukleinsäuren und -polypeptide
EP1276751A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1765993A4 (fr) Polypeptides st6galnacl tronques et acides nucleiques
EP1483386A4 (fr) Nouveaux acides nucleiques et polypeptides secretes
EP1381621A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1470238A4 (fr) Nouveaux acides nucleiques et polypeptides
AU2002368010A8 (en) Novel nucleic acids and secreted polypeptides
AU2003226416A8 (en) Polypeptides having xyloglucanase activity and nucleic acids encoding same
EP1430112A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1527180A4 (fr) Acides nucleiques et polypeptides se rapportant a l'enzyme homogentisate prenyl transferase ("hpt"), et utilisations correspondantes
EP1341803A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1565553A4 (fr) Polypeptides catalytiques recombinants et leurs utilisations
EP1359932A4 (fr) Polypeptides tip39
EP1268762A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1282635A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1370675A4 (fr) Nouveaux acides nucleiques et polypeptides
DE60028365D1 (de) Chimäre nukleinsäuren und polypeptide aus lyssavirus
DE60217711D1 (de) Ptp10d nukleinsäuren und peptide in der regulation von energie-homeostase

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050427

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

A4 Supplementary search report drawn up and despatched

Effective date: 20060221

17Q First examination report despatched

Effective date: 20061207

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20070418